Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $608.8000 (1.01%) ($603.1450 - $618.7700) on Thu. Jan. 27, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.82% (three month average) | RSI | 58 | Latest Price | $608.8000(1.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | Weekly Trend | REGN declines -0.5% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(54%) DIA(40%) IWD(39%) XLV(39%) SPLV(37%) | Factors Impacting REGN price | REGN will decline at least -0.91% in a week (0% probabilities). VIXM(-18%) TBT(-10%) UUP(-8%) VXX(-3%) USO(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.91% (StdDev 1.82%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $615.77 | 5 Day Moving Average | $610.91(-0.35%) | 10 Day Moving Average | $612.59(-0.62%) | 20 Day Moving Average | $615.77(-1.13%) | To recent high | -9.2% | To recent low | 3.2% | Market Cap | $64.55b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |